TMCnet News
In-Vitro Toxicology/Toxicity Testing (Cell Culture, HTS, Omics) Market - Global Forecasts to 2018(Marketwire (Canada) Via Acquire Media NewsEdge) DUBLIN, IRELAND--(Marketwired - July 28, 2014) - Research and Markets (http://www.researchandmarkets.com/research/w7rp9l/invitro) has announced the addition of the "In-Vitro Toxicology/ Toxicity Testing Market by Industry, Technology, Applications & Method - Global Forecast to 2018" report to their offering. The global market of in-vitro toxicology testing is subdivided into industry, technology, method, application and geography. On the basis of industry, the market is further segmented into diagnostics, pharmaceuticals, chemicals, cosmetics, and food. Diagnostics is further categorized into sample and type. The largest market share was captured by the pharmaceutical industry, whereas cosmetics industry was the fastest growing industry with a double digit CAGR. The prime factor contributing to the growth of pharmaceutical industry has been the attention towards the detection of toxicity during earlier stages of development. On the basis of technology, the global market of in vitro toxicology testing is divided into cell culture, high throughput screening, cellular imaging, and omics technologies. Cell culture technology will witness the maximum growth rate in the coming years. The methods considered for the study are cellular assays, biochemical assays, ex vivo and in silico. Cellular assays market is estimated to grow at a double digit CAGR during the forecast period (2013-2018). Cellular assays can predict the biological properties of potential drug compounds. These assays can also detect and measure cell viability, functionality and growth. Under the applications, the market is segmented into systemic toxicity, dermal toxicity, ocular toxicity, endocrine disruption (reproductive & developmental toxicity) and others. Systemic toxicity testing was the largest segment in 2013. The increasing focus on detection of toxicity in earlier stages of development is leading to persistent requirement for human cell-based in vitro models for cardiotoxicity and liver toxicity testing which are the major reasons for drug attrition. Europe commanded the largest share of the global market in 2013. This is attributed to the support provided by the European government for anti-animal testing laws. The government has further put ban on the production and sale of all animal tested cosmetics across the continent. The market will be driven by increasing acceptance of in-vitro toxicology testing methods as alternatives to in vivo toxicology testing. The new technologies in the in vitro testing market help in investigating the adverse effects of environmental agents in a more mechanistic and time saving manner. Organizations such as REACH foresee that more results of in vitro and in silico methods will be included in risk assessment which will promote the use of in vitro methods for toxicology testing. Scope Industry -- Diagnostic -- Pharmaceutical -- Cosmetics -- Chemical Technology -- Cell Culture -- HTS -- Omics Applications -- Systemic -- Dermal -- Ocular Method -- Cellular Assay -- Ex vivo -- In Silico Key Topics Covered: 1. Introduction 2. Executive Summary 3. Premium Insights 4. Market Overview 5. By Industry 6. By Technology 7. By Application 8. By Method 9. Geographic Analysis 10. Competitive Landscape 11. Company Profiles -- Agilent Technologies, Inc. -- Alere, Inc. -- Bio-Rad Laboratories, Inc. -- Bioreliance, Inc. -- Catalent -- Charles River Laboratories International, Inc. -- Covance, Inc. -- Cyprotex -- Eurofins Scientific -- GE Healthcare -- Life Technologies Corporation -- Quest DiagnosticsVisit http://www.researchandmarkets.com/research/w7rp9l/invitro Sector: Biotechnology Over 400 of the Fortune 500 buy their research from Research and Markets. Some of our clients in the area of Biotechnology include: -- IGEN Biotech Group -- BASF -- McKinsey & Company, Inc. -- Mitsubishi Research Institute, Inc. -- Beiersdorf AG -- NPS Pharmaceuticals, Inc. -- Vertex Pharmaceuticals -- Beckman Coulter Genomics -- Baxter Innovations GmbH -- Otsuka Pharmaceutical Company -- Bio Springer -- Qiagen -- Amgen -- Yale University FOR FURTHER INFORMATION PLEASE CONTACT: Research and Markets Laura Wood, Senior Manager [email protected] U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Source: Research and Markets |